|
Mechanism5-HT receptor antagonists [+1] |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date31 Jul 2009 |
100 Clinical Results associated with Romei Pharmaceutical (Shijiazhuang) Co., Ltd.
0 Patents (Medical) associated with Romei Pharmaceutical (Shijiazhuang) Co., Ltd.
100 Deals associated with Romei Pharmaceutical (Shijiazhuang) Co., Ltd.
100 Translational Medicine associated with Romei Pharmaceutical (Shijiazhuang) Co., Ltd.